메뉴 건너뛰기




Volumn 11, Issue 1, 2013, Pages

High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma

Author keywords

Advanced hepatocellular carcinoma; Cryoablation; Efficacy; Metastasis associated in colon cancer 1 (MACC1); Outcomes; Safety

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 84873737594     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-41     Document Type: Article
Times cited : (41)

References (48)
  • 2
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • 10.1002/hep.20933, 16250051
    • Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. 10.1002/hep.20933, 16250051.
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 4
    • 1242307263 scopus 로고    scopus 로고
    • Barcelona-clinic liver cancer group: The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma
    • Llovet JM, Fuster J, Bruix J. Barcelona-clinic liver cancer group: The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004, 10(suppl 1):S115-S120.
    • (2004) Liver Transpl , vol.10 , Issue.SUPPL. 1
    • Llovet, J.M.1    Fuster, J.2    Bruix, J.3
  • 6
    • 57749189578 scopus 로고    scopus 로고
    • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    • 10.1016/S1470-2045(08)70285-7, 19095497
    • Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009, 10:25-34. 10.1016/S1470-2045(08)70285-7, 19095497.
    • (2009) Lancet Oncol , vol.10 , pp. 25-34
    • Cheng, A.L.1    Kang, Y.K.2    Chen, Z.3    Tsao, C.J.4    Qin, S.5    Kim, J.S.6    Luo, R.7    Feng, J.8    Ye, S.9    Yang, T.S.10
  • 7
    • 0030207619 scopus 로고    scopus 로고
    • Cryosurgical ablation of unresectable hepatic tumors
    • 239-244
    • Zuro LM, Staren ED. Cryosurgical ablation of unresectable hepatic tumors. AORN J 1996, 64:231-236. 239-244.
    • (1996) AORN J , vol.64 , pp. 231-236
    • Zuro, L.M.1    Staren, E.D.2
  • 8
    • 0032055869 scopus 로고    scopus 로고
    • Cryosurgery as a Treatment for Advanced Stage Hepatocellular Carcinoma. Results, Complications, and Alcohol Ablation
    • 10.1002/(SICI)1097-0142(19980401)82:7<1268::AID-CNCR9>3.0.CO;2-B, 9529018
    • Wong WS, Patel SC, Cruz FS. Cryosurgery as a Treatment for Advanced Stage Hepatocellular Carcinoma. Results, Complications, and Alcohol Ablation. Cancer 1998, 82:1268-1278. 10.1002/(SICI)1097-0142(19980401)82:7<1268::AID-CNCR9>3.0.CO;2-B, 9529018.
    • (1998) Cancer , vol.82 , pp. 1268-1278
    • Wong, W.S.1    Patel, S.C.2    Cruz, F.S.3
  • 9
    • 34248162563 scopus 로고    scopus 로고
    • Serum cytokine levels in response to hepatic cryoablation
    • 10.1002/jso.20712, 17219394
    • Osada S, Imai H, Tomita H. Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol 2007, 95:491-498. 10.1002/jso.20712, 17219394.
    • (2007) J Surg Oncol , vol.95 , pp. 491-498
    • Osada, S.1    Imai, H.2    Tomita, H.3
  • 11
    • 77956921254 scopus 로고    scopus 로고
    • Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma
    • 10.1007/s00535-010-0243-3, 20411280
    • Zhou L, Fu JL, Lu YY, Fu BY, Wang CP, An LJ, Wang XZ, Zeng Z, Zhou CB, Yang YP. Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol 2010, 45:968-978. 10.1007/s00535-010-0243-3, 20411280.
    • (2010) J Gastroenterol , vol.45 , pp. 968-978
    • Zhou, L.1    Fu, J.L.2    Lu, Y.Y.3    Fu, B.Y.4    Wang, C.P.5    An, L.J.6    Wang, X.Z.7    Zeng, Z.8    Zhou, C.B.9    Yang, Y.P.10
  • 12
    • 79952107658 scopus 로고    scopus 로고
    • Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma
    • 10.1016/j.ijsu.2010.11.008, 21093616
    • Chen HW, Lai EC, Zhen ZJ, Cui WZ, Liao S, Lau WY. Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. Int J Surg 2011, 9:188-191. 10.1016/j.ijsu.2010.11.008, 21093616.
    • (2011) Int J Surg , vol.9 , pp. 188-191
    • Chen, H.W.1    Lai, E.C.2    Zhen, Z.J.3    Cui, W.Z.4    Liao, S.5    Lau, W.Y.6
  • 13
    • 58249089275 scopus 로고    scopus 로고
    • Cryo-immunology: A review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses
    • 10.1016/j.cryobiol.2008.10.126, 19007768
    • Sabel MS. Cryo-immunology: A review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 2009, 58:1-11. 10.1016/j.cryobiol.2008.10.126, 19007768.
    • (2009) Cryobiology , vol.58 , pp. 1-11
    • Sabel, M.S.1
  • 14
    • 58149352266 scopus 로고    scopus 로고
    • MACC1, a newly identified key regulator of HGF/Met signaling, predicts colon cancer metastasis
    • 10.1038/nm.1889, 19098908
    • Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM. MACC1, a newly identified key regulator of HGF/Met signaling, predicts colon cancer metastasis. Nat Med 2009, 15:59-67. 10.1038/nm.1889, 19098908.
    • (2009) Nat Med , vol.15 , pp. 59-67
    • Stein, U.1    Walther, W.2    Arlt, F.3    Schwabe, H.4    Smith, J.5    Fichtner, I.6    Birchmeier, W.7    Schlag, P.M.8
  • 17
    • 84863104639 scopus 로고    scopus 로고
    • Overexpression of Metastasis-Associated in Colon Cancer-1 Predicts a Poor Outcome of HBV-Related Hepatocellular Carcinoma
    • 10.3748/wjg.v18.i23.2995, 3380328, 22736924
    • Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, Zeng Z, Wang CP, An LJ, Hao LY. Overexpression of Metastasis-Associated in Colon Cancer-1 Predicts a Poor Outcome of HBV-Related Hepatocellular Carcinoma. World J Gastroenterol 2012, 18:2995-3003. 10.3748/wjg.v18.i23.2995, 3380328, 22736924.
    • (2012) World J Gastroenterol , vol.18 , pp. 2995-3003
    • Qu, J.H.1    Chang, X.J.2    Lu, Y.Y.3    Bai, W.L.4    Chen, Y.5    Zhou, L.6    Zeng, Z.7    Wang, C.P.8    An, L.J.9    Hao, L.Y.10
  • 18
    • 80053172942 scopus 로고    scopus 로고
    • Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
    • 10.1186/1479-5876-9-166, 3192685, 21955323
    • Qiu JL, Huang PZ, Liu Q, Hong J, Li BK, Lu CL, Wang L, Wang JP, Yuan YF. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 2011, 9:166-175. 10.1186/1479-5876-9-166, 3192685, 21955323.
    • (2011) J Transl Med , vol.9 , pp. 166-175
    • Qiu, J.L.1    Huang, P.Z.2    Liu, Q.3    Hong, J.4    Li, B.K.5    Lu, C.L.6    Wang, L.7    Wang, J.P.8    Yuan, Y.F.9
  • 20
    • 79959596934 scopus 로고    scopus 로고
    • Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis
    • 10.3350/kjhep.2010.16.4.369, 3304612, 21415580
    • Lee HS, Kim JK, Cheong JY, Han EJ, An SY, Song JH, Jung YJ, Jeon SC, Jung MW, Jang EJ. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. Korean J Hepatol 2010, 16:369-375. 10.3350/kjhep.2010.16.4.369, 3304612, 21415580.
    • (2010) Korean J Hepatol , vol.16 , pp. 369-375
    • Lee, H.S.1    Kim, J.K.2    Cheong, J.Y.3    Han, E.J.4    An, S.Y.5    Song, J.H.6    Jung, Y.J.7    Jeon, S.C.8    Jung, M.W.9    Jang, E.J.10
  • 22
    • 71849120363 scopus 로고    scopus 로고
    • Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study
    • 10.1007/s10585-009-9283-6, 19784786
    • Wang CP, Lu YY, Chen Y, Feng YY, An LJ, Wang XZ, Su SH, Bai WL, Zhou L, Yang YP. Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clin Exp Metastasis 2009, 26:839-848. 10.1007/s10585-009-9283-6, 19784786.
    • (2009) Clin Exp Metastasis , vol.26 , pp. 839-848
    • Wang, C.P.1    Lu, Y.Y.2    Chen, Y.3    Feng, Y.Y.4    An, L.J.5    Wang, X.Z.6    Su, S.H.7    Bai, W.L.8    Zhou, L.9    Yang, Y.P.10
  • 23
    • 33745529808 scopus 로고    scopus 로고
    • New aspects of diagnosis and therapy of hepatocellular carcinoma
    • 10.1038/sj.onc.1209548, 16799626
    • Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 2006, 25:3848-3856. 10.1038/sj.onc.1209548, 16799626.
    • (2006) Oncogene , vol.25 , pp. 3848-3856
    • Bruix, J.1    Hessheimer, A.J.2    Forner, A.3    Boix, L.4    Vilana, R.5    Llovet, J.M.6
  • 24
    • 84872179078 scopus 로고    scopus 로고
    • Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma
    • 10.1007/s00534-011-0490-6, 3501181, 22187145
    • Yang YP, Wang CP, Lu YY, Bai WL, An LJ, Qu JH, Gao XD, Chen Y, Zhou L, Wu Y. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2012, 19:674-684. 10.1007/s00534-011-0490-6, 3501181, 22187145.
    • (2012) J Hepatobiliary Pancreat Sci , vol.19 , pp. 674-684
    • Yang, Y.P.1    Wang, C.P.2    Lu, Y.Y.3    Bai, W.L.4    An, L.J.5    Qu, J.H.6    Gao, X.D.7    Chen, Y.8    Zhou, L.9    Wu, Y.10
  • 25
    • 44949231424 scopus 로고    scopus 로고
    • Analyzing real-time PCR data by the comparative C (T) method
    • 10.1038/nprot.2008.73, 18546601
    • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
    • (2008) Nat Protoc , vol.3 , pp. 1101-1108
    • Schmittgen, T.D.1    Livak, K.J.2
  • 26
    • 47749103018 scopus 로고    scopus 로고
    • Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study
    • 10.1007/s11605-007-0310-0, 17943391
    • Wang ZL, Liang P, Dong BW, Yu XL, Yu DJ. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg 2008, 12:327-337. 10.1007/s11605-007-0310-0, 17943391.
    • (2008) J Gastrointest Surg , vol.12 , pp. 327-337
    • Wang, Z.L.1    Liang, P.2    Dong, B.W.3    Yu, X.L.4    Yu, D.J.5
  • 27
    • 0642307263 scopus 로고    scopus 로고
    • The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time
    • 10.1200/JCO.2003.11.137, 14581446
    • Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003, 21:4329-4335. 10.1200/JCO.2003.11.137, 14581446.
    • (2003) J Clin Oncol , vol.21 , pp. 4329-4335
    • Yoo, H.Y.1    Patt, C.H.2    Geschwind, J.F.3    Thuluvath, P.J.4
  • 28
    • 33646567160 scopus 로고    scopus 로고
    • Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials
    • 10.1111/j.1365-2036.2006.02932.x, 16696801
    • Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006, 23:1535-1547. 10.1111/j.1365-2036.2006.02932.x, 16696801.
    • (2006) Aliment Pharmacol Ther , vol.23 , pp. 1535-1547
    • Lopez, P.M.1    Villanueva, A.2    Llovet, J.M.3
  • 29
    • 14344258798 scopus 로고    scopus 로고
    • Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model
    • 10.1245/ASO.2004.10.027, 15231521
    • Ng KK, Lam CM, Poon RT, Shek TW, To JY, Wo YH, Ho DW, Fan ST. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol 2004, 11:650-657. 10.1245/ASO.2004.10.027, 15231521.
    • (2004) Ann Surg Oncol , vol.11 , pp. 650-657
    • Ng, K.K.1    Lam, C.M.2    Poon, R.T.3    Shek, T.W.4    To, J.Y.5    Wo, Y.H.6    Ho, D.W.7    Fan, S.T.8
  • 30
    • 28244493625 scopus 로고    scopus 로고
    • Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma
    • Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 2005, 29:1-10.
    • (2005) World J Surg , vol.29 , pp. 1-10
    • Machi, J.1    Bueno, R.S.2    Wong, L.L.3
  • 31
    • 9744265831 scopus 로고    scopus 로고
    • Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma
    • 10.1002/hep.20465, 15565564, Barcelona Clínic Liver Cancer Group
    • Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J, Barcelona Clínic Liver Cancer Group Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004, 40:1352-1360. 10.1002/hep.20465, 15565564, Barcelona Clínic Liver Cancer Group.
    • (2004) Hepatology , vol.40 , pp. 1352-1360
    • Sala, M.1    Llovet, J.M.2    Vilana, R.3    Bianchi, L.4    Solé, M.5    Ayuso, C.6    Brú, C.7    Bruix, J.8
  • 32
    • 23744497031 scopus 로고    scopus 로고
    • Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis
    • 10.1245/ASO.2005.06.011, 15965731
    • Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005, 12:616-628. 10.1245/ASO.2005.06.011, 15965731.
    • (2005) Ann Surg Oncol , vol.12 , pp. 616-628
    • Raut, C.P.1    Izzo, F.2    Marra, P.3    Ellis, L.M.4    Vauthey, J.N.5    Cremona, F.6    Vallone, P.7    Mastro, A.8    Fornage, B.D.9    Curley, S.A.10
  • 33
    • 44649156439 scopus 로고    scopus 로고
    • Technologies for ablation of hepatocellular carcinoma
    • 10.1053/j.gastro.2008.05.022, 18486619
    • Callstrom MR, Charboneau JW. Technologies for ablation of hepatocellular carcinoma. Gastroenterology 2008, 134:1831-1835. 10.1053/j.gastro.2008.05.022, 18486619.
    • (2008) Gastroenterology , vol.134 , pp. 1831-1835
    • Callstrom, M.R.1    Charboneau, J.W.2
  • 36
    • 25144473037 scopus 로고    scopus 로고
    • Pain control requirements for percutaneous ablation of renal tumors:cryoablation versus radiofrequency ablation-initial observations
    • 10.1148/radiol.2371040829, 16126920
    • Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors:cryoablation versus radiofrequency ablation-initial observations. Radiology 2005, 237:366-370. 10.1148/radiol.2371040829, 16126920.
    • (2005) Radiology , vol.237 , pp. 366-370
    • Allaf, M.E.1    Varkarakis, I.M.2    Bhayani, S.B.3    Inagaki, T.4    Kavoussi, L.R.5    Solomon, S.B.6
  • 38
    • 0035028475 scopus 로고    scopus 로고
    • Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
    • 10.1053/jhep.2001.24233, 11343240, Barcelona Clínic Liver Cancer (BCLC) Group
    • Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Barcelona Clínic Liver Cancer (BCLC) Group Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001, 33:1124-1129. 10.1053/jhep.2001.24233, 11343240, Barcelona Clínic Liver Cancer (BCLC) Group.
    • (2001) Hepatology , vol.33 , pp. 1124-1129
    • Llovet, J.M.1    Vilana, R.2    Brú, C.3    Bianchi, L.4    Salmeron, J.M.5    Boix, L.6    Ganau, S.7    Sala, M.8    Pagès, M.9    Ayuso, C.10
  • 39
    • 84862495798 scopus 로고    scopus 로고
    • US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results
    • Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Wang XH. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Eur J Radiol 2012, 263:900-908.
    • (2012) Eur J Radiol , vol.263 , pp. 900-908
    • Yu, J.1    Liang, P.2    Yu, X.L.3    Cheng, Z.G.4    Han, Z.Y.5    Mu, M.J.6    Wang, X.H.7
  • 40
    • 4744371527 scopus 로고    scopus 로고
    • Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors
    • 10.1016/j.surg.2004.07.001, 15467661
    • Kerkar S, Carlin AM, Sohn RL, Steffes C, Tyburski J, Littrup P, Weaver D. Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors. Surgery 2004, 136:770-779. 10.1016/j.surg.2004.07.001, 15467661.
    • (2004) Surgery , vol.136 , pp. 770-779
    • Kerkar, S.1    Carlin, A.M.2    Sohn, R.L.3    Steffes, C.4    Tyburski, J.5    Littrup, P.6    Weaver, D.7
  • 42
    • 84861228215 scopus 로고    scopus 로고
    • Cryotherapy is associated with improved clinical outcomes of sorafenib therapy for advanced hepatocellular carcinoma
    • 10.1007/s12013-012-9353-2, 3353117, 22477032
    • Yang Y, Lu Y, Wang C, Bai W, Qu J, Chen Y, Chang X, An L, Zhou L, Zeng Z. Cryotherapy is associated with improved clinical outcomes of sorafenib therapy for advanced hepatocellular carcinoma. Cell Biochem Biophys 2012, 63:159-169. 10.1007/s12013-012-9353-2, 3353117, 22477032.
    • (2012) Cell Biochem Biophys , vol.63 , pp. 159-169
    • Yang, Y.1    Lu, Y.2    Wang, C.3    Bai, W.4    Qu, J.5    Chen, Y.6    Chang, X.7    An, L.8    Zhou, L.9    Zeng, Z.10
  • 44
    • 0034782172 scopus 로고    scopus 로고
    • Establishment of cell clones with different metastatic potential from the metastatic hepatocellularcarcinoma cell line MHCC97
    • Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Establishment of cell clones with different metastatic potential from the metastatic hepatocellularcarcinoma cell line MHCC97. World J Gastroenterol 2001, 7:630-636.
    • (2001) World J Gastroenterol , vol.7 , pp. 630-636
    • Li, Y.1    Tang, Z.Y.2    Ye, S.L.3    Liu, Y.K.4    Chen, J.5    Xue, Q.6    Chen, J.7    Gao, D.M.8    Bao, W.H.9
  • 47
    • 84865959411 scopus 로고    scopus 로고
    • Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area
    • 10.1016/j.clinre.2011.12.018, 22326248
    • Kang HY, Shin HD, Kim SB, Song IH. Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area. Clin Res Hepatol Gastroenterol 2012, 36:357-364. 10.1016/j.clinre.2011.12.018, 22326248.
    • (2012) Clin Res Hepatol Gastroenterol , vol.36 , pp. 357-364
    • Kang, H.Y.1    Shin, H.D.2    Kim, S.B.3    Song, I.H.4
  • 48
    • 62749123476 scopus 로고    scopus 로고
    • Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
    • 10.1111/j.1478-3231.2008.01957.x, 2711257, 19141028
    • Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009, 29:502-508. 10.1111/j.1478-3231.2008.01957.x, 2711257, 19141028.
    • (2009) Liver Int , vol.29 , pp. 502-508
    • Tandon, P.1    Garcia-Tsao, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.